FERRARI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 1.168
EU - Europa 393
AS - Asia 151
AF - Africa 2
Totale 1.714
Nazione #
US - Stati Uniti d'America 1.166
GB - Regno Unito 136
DE - Germania 69
IT - Italia 66
SG - Singapore 51
SE - Svezia 46
CN - Cina 40
IN - India 19
TR - Turchia 19
UA - Ucraina 19
FI - Finlandia 16
HK - Hong Kong 16
BE - Belgio 12
BG - Bulgaria 9
RU - Federazione Russa 8
FR - Francia 5
ID - Indonesia 4
NL - Olanda 3
CA - Canada 2
ZA - Sudafrica 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
SI - Slovenia 1
Totale 1.714
Città #
Fairfield 196
Santa Clara 108
Southend 106
Chandler 99
Woodbridge 95
Ashburn 93
Seattle 90
Houston 68
Wilmington 59
Cambridge 49
Ann Arbor 47
Dearborn 45
Singapore 40
Modena 35
Nyköping 34
Jacksonville 31
Hong Kong 16
Izmir 15
Helsinki 14
Brussels 12
New York 11
Bremen 9
Princeton 9
Redwood City 9
Sofia 9
Beijing 8
Grafing 8
Eugene 7
Shanghai 7
Chicago 6
San Diego 6
Leawood 5
Jakarta 4
London 4
Los Angeles 4
Munich 4
Naples 4
Kilburn 3
Amsterdam 2
Chongqing 2
Dallas 2
Ferrara 2
Formigine 2
Muizenberg 2
Pozzo 2
Acton 1
Apo 1
Ardabil 1
Ascoli Piceno 1
Augusta 1
Baotou 1
Bologna 1
Brno 1
Chiswick 1
Clearwater 1
Fremont 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Jinan 1
Lanzhou 1
Markham 1
Modesto 1
Montefiore Conca 1
Moscow 1
Norwalk 1
Novokuznetsk 1
Phoenix 1
Pontevedra 1
Prescot 1
Reggio Emilia 1
Sacramento 1
San Francisco 1
San Mateo 1
Shaoxing 1
Shenyang 1
Shenzhen 1
Shijiazhuang 1
Toronto 1
Xiamen 1
Zurich 1
Totale 1.419
Nome #
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 292
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 291
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 214
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 208
Missed treatment in an Italian HBV infected patients cohort: HBV RER 206
From current status to optimization of HCV treatment: Recommendations from an expert panel 177
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 135
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group 114
CFD analysis of compensator for meter out sensing system 98
Totale 1.735
Categoria #
all - tutte 6.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020217 0 0 0 0 0 79 50 25 32 9 18 4
2020/2021459 24 14 44 56 43 65 96 34 24 22 26 11
2021/2022209 16 10 9 18 3 9 15 19 18 21 42 29
2022/2023221 26 32 24 29 27 29 2 14 22 0 11 5
2023/2024111 6 8 12 11 11 12 11 11 2 4 3 20
2024/2025193 19 0 6 31 79 58 0 0 0 0 0 0
Totale 1.735